WELL Health Technologies Corp T.WELL

Alternate Symbol(s): WHTCF | T.WELL.DB

Healthcare

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.

TSX:WELL - Post by User

WELL Health Technologies Corp > Another View

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Nov 08, 2024 6:43am

244 Views

Post# 36302564

Another View

What are your thoughts on the quarter and guidance for Well Health? Is it still on your small/mid cap favorite list? If yes where would you list in your top 5 choices?

WELL EPS was 5c, off estimates of 5.5c; revenue of $251.7M beat estimates of $247M. EBITDA of $32.7M beat estimates by 2%. Gross margin was 44.6%. Revenue guidance was raised to $985M+, from $970M+. EBITDA range was also raised. Its $1B run rate was achieved ahead of plan. Revenue rose 27%; EBITDA rose 16%. Patient visits increased 41%. It was a solid quarter/outlook and the stock finally made a move today.

We would consider: TVK, HPS.A, WELL, TCS, VHI as favourites in order.

and as a result..........

Growth Model Portfolio

Increase Well Health Technologies (WELL) Position to a 4.0% Weighting

Trade Rationale - WELL reported earnings today, with revenue guidance being raised and its EBITDA range also raised. WELL’s $1 billion run rate was achieved ahead of plan, and overall it was a strong quarter/outlook which caused the stock to make a move. We like the fundamentals of WELL, and with rates declining, we feel that it can both improve its margins and make potential acquisitions with a lower cost of capital.